Oncotarget

Trending with Impact: Benign, Borderline, and Malignant Breast Tumors

Mar 19, 2021
Exploring the distinctions between benign, borderline, and malignant breast tumors through proteomics. Highlighting potential prognostic markers and mechanisms driving progression from borderline to malignant states in fibroepithelial lesions.
Ask episode
Chapters
Transcript
Episode notes